{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:05:11Z","timestamp":1790784311617,"version":"4.1.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"DOI":"10.1038\/s41574-026-01303-3","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:32Z","timestamp":1790154452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and management of Silver\u2013Russell syndrome: second international consensus statement"],"prefix":"10.1038","author":[{"given":"Emma","family":"Wakeling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin H.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-8616","authenticated-orcid":false,"given":"Elo\u00efse","family":"Giabicani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine D.","family":"Harbison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Perriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4266-170X","authenticated-orcid":false,"given":"Jennifer B.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-8437","authenticated-orcid":false,"given":"Matthias","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-3587","authenticated-orcid":false,"given":"Gerhard","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-760X","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Brioude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9542-685X","authenticated-orcid":false,"given":"Dayna","family":"Morris-Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovanna","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bea","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Donadille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-5344","authenticated-orcid":false,"given":"Beatrice","family":"Dubern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Eggermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gazdagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2341-1326","authenticated-orcid":false,"given":"Karen","family":"Gr\u00f8nskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.","family":"Hokken Koelega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Hee","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Jurians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Kulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmahane","family":"Ladjouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5917-8020","authenticated-orcid":false,"given":"Louise","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mericq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7990-3576","authenticated-orcid":false,"given":"Andrea","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-0193","authenticated-orcid":false,"given":"Silvia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-1931","authenticated-orcid":false,"given":"Helen L.","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Karen","family":"Temple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-5802","authenticated-orcid":false,"given":"Zeynep","family":"T\u00fcmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8419-0264","authenticated-orcid":false,"given":"Thomas","family":"Eggermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-4401","authenticated-orcid":false,"given":"Deborah J. G.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-3389","authenticated-orcid":false,"given":"Irene","family":"Netchine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"1303_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrendo.2016.138","volume":"13","author":"EL Wakeling","year":"2017","unstructured":"Wakeling, E. L. et al. Diagnosis and management of Silver\u2013Russell syndrome: first international Consensus Statement. Nat. Rev. Endocrinol. 13, 105\u2013124 https:\/\/doi.org\/10.1038\/nrendo.2016.138 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1303_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jmedgenet-2014-102979","volume":"52","author":"S Azzi","year":"2015","unstructured":"Azzi, S. et al. A prospective study validating a clinical scoring system and demonstrating phenotypical\u2013genotypical correlations in Silver\u2013Russell syndrome. J. Med. Genet. 52, 446\u2013453 https:\/\/doi.org\/10.1136\/jmedgenet-2014-102979 (2015).","journal-title":"J. Med. Genet."},{"key":"1303_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/jmg.2010.079111","volume":"47","author":"EL Wakeling","year":"2010","unstructured":"Wakeling, E. L. et al. Epigenotype\u2013phenotype correlations in Silver\u2013Russell syndrome. J. Med. Genet. 47, 760\u2013768 https:\/\/doi.org\/10.1136\/jmg.2010.079111 (2010).","journal-title":"J. Med. Genet."},{"key":"1303_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/13611260500069947","volume":"27","author":"MR de Villiers","year":"2005","unstructured":"de Villiers, M. R., de Villiers, P. J. & Kent, A. P. The Delphi technique in health sciences education research. Med. Teach. 27, 639\u2013643 https:\/\/doi.org\/10.1080\/13611260500069947 (2005).","journal-title":"Med. Teach."},{"key":"1303_CR5","doi-asserted-by":"publisher","unstructured":"Challiol, M. et al. Diagnosis of silver russell syndrome in 2025: is a scoring system still helpful? [abstract JOINT349]. Presented at the Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025 Endocr. Abstr. https:\/\/doi.org\/10.1530\/endoabs.110.P618 (2025).","DOI":"10.1530\/endoabs.110.P618"},{"key":"1303_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jpeds.2017.04.018","volume":"187","author":"R Meyer","year":"2017","unstructured":"Meyer, R. et al. Targeted next generation sequencing approach in patients referred for Silver\u2013Russell syndrome testing increases the mutation detection rate and provides decisive information for clinical management. J. Pediatr. 187, 206\u2013212.e1 https:\/\/doi.org\/10.1016\/j.jpeds.2017.04.018 (2017).","journal-title":"J. Pediatr."},{"key":"1303_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00865-x","volume":"12","author":"T Inoue","year":"2020","unstructured":"Inoue, T. et al. Contribution of gene mutations to Silver\u2013Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients. Clin. Epigenetics 12, 86 https:\/\/doi.org\/10.1186\/s13148-020-00865-x (2020).","journal-title":"Clin. Epigenetics"},{"key":"1303_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s10038-022-01048-7","volume":"67","author":"T Fuke","year":"2022","unstructured":"Fuke, T. et al. Frequency and clinical characteristics of distinct etiologies in patients with Silver\u2013Russell syndrome diagnosed based on the Netchine\u2013Harbison clinical scoring system. J. Hum. Genet. 67, 607\u2013611 https:\/\/doi.org\/10.1038\/s10038-022-01048-7 (2022).","journal-title":"J. Hum. Genet."},{"key":"1303_CR9","doi-asserted-by":"publisher","first-page":"e932","DOI":"10.1210\/clinem\/dgae730","volume":"110","author":"A Vimercati","year":"2025","unstructured":"Vimercati, A. et al. Distinguishing genetic alterations versus (epi)mutations in Silver\u2013Russell syndrome and focus on the IGF1R gene. J. Clin. Endocrinol. Metab. 110, e932\u2013e944 https:\/\/doi.org\/10.1210\/clinem\/dgae730 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/jmedgenet-2019-106561","volume":"57","author":"O Lokulo-Sodipe","year":"2020","unstructured":"Lokulo-Sodipe, O. et al. Phenotype of genetically confirmed Silver\u2013Russell syndrome beyond childhood. J. Med. Genet. 57, 683\u2013691 https:\/\/doi.org\/10.1136\/jmedgenet-2019-106561 (2020).","journal-title":"J. Med. Genet."},{"key":"1303_CR11","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1210\/jc.2007-0354","volume":"92","author":"I Netchine","year":"2007","unstructured":"Netchine, I. et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell\u2013Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J. Clin. Endocrinol. Metab. 92, 3148\u20133154 https:\/\/doi.org\/10.1210\/jc.2007-0354 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1210\/jc.2007-1897","volume":"93","author":"G Binder","year":"2008","unstructured":"Binder, G. et al. The endocrine phenotype in Silver\u2013Russell syndrome is defined by the underlying epigenetic alteration. J. Clin. Endocrinol. Metab. 93, 1402\u20131407 https:\/\/doi.org\/10.1210\/jc.2007-1897 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/jmg.2008.061820","volume":"46","author":"D Bartholdi","year":"2009","unstructured":"Bartholdi, D. et al. Epigenetic mutations of the imprinted IGF2-H19 domain in Silver\u2013Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes. J. Med. Genet. 46, 192\u2013197 https:\/\/doi.org\/10.1136\/jmg.2008.061820 (2009).","journal-title":"J. Med. Genet."},{"key":"1303_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1210\/jc.2008-1805","volume":"94","author":"S Bruce","year":"2009","unstructured":"Bruce, S., Hannula-Jouppi, K., Peltonen, J., Kere, J. & Lipsanen-Nyman, M. Clinically distinct epigenetic subgroups in Silver\u2013Russell syndrome: the degree of H19 hypomethylation associates with phenotype severity and genital and skeletal anomalies. J. Clin. Endocrinol. Metab. 94, 579\u2013587 https:\/\/doi.org\/10.1210\/jc.2008-1805 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111197","volume":"11","author":"HY Lin","year":"2021","unstructured":"Lin, H. Y. et al. Epigenotype, genotype, and phenotype analysis of Taiwanese patients with Silver\u2013Russell syndrome. J. Pers. Med. 11, 1197 https:\/\/doi.org\/10.3390\/jpm11111197 (2021).","journal-title":"J. Pers. Med."},{"key":"1303_CR16","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1210\/jc.2015-4273","volume":"101","author":"CC Smeets","year":"2016","unstructured":"Smeets, C. C., Zandwijken, G. R., Renes, J. S. & Hokken-Koelega, A. C. Long-term results of GH treatment in Silver\u2013Russell syndrome (SRS): do they benefit the same as non-SRS short-SGA? J. Clin. Endocrinol. Metab. 101, 2105\u20132112 https:\/\/doi.org\/10.1210\/jc.2015-4273 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1037\/abn0000481","volume":"129","author":"C Lane","year":"2020","unstructured":"Lane, C., Robinson, L. & Freeth, M. Autistic traits and cognitive abilities associated with two molecular causes of Silver\u2013Russell syndrome. J. Abnorm. Psychol. 129, 312\u2013319 https:\/\/doi.org\/10.1037\/abn0000481 (2020).","journal-title":"J. Abnorm. Psychol."},{"key":"1303_CR18","doi-asserted-by":"publisher","first-page":"e1478","DOI":"10.1210\/clinem\/dgz151","volume":"105","author":"G Patti","year":"2020","unstructured":"Patti, G. et al. Cognitive profiles and brain volume are affected in patients with Silver\u2013Russell syndrome. J. Clin. Endocrinol. Metab. 105, e1478\u2013e1488 https:\/\/doi.org\/10.1210\/clinem\/dgz151 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR19","doi-asserted-by":"publisher","unstructured":"Jain, S. et al. Neurodevelopmental outcomes in Silver\u2013Russell syndrome: the impact of molecular causes [abstract JOINT1531]. Presented at the Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025 Endocr. Abstr. https:\/\/doi.org\/10.1530\/endoabs.110.RC14.4 (2025).","DOI":"10.1530\/endoabs.110.RC14.4"},{"key":"1303_CR20","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/ajmg.a.36464","volume":"164A","author":"S Fokstuen","year":"2014","unstructured":"Fokstuen, S. & Kotzot, D. Chromosomal rearrangements in patients with clinical features of Silver\u2013Russell syndrome. Am. J. Med. Genet. A 164A, 1595\u20131605 https:\/\/doi.org\/10.1002\/ajmg.a.36464 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"1303_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1086\/502981","volume":"78","author":"J Bliek","year":"2006","unstructured":"Bliek, J. et al. Hypomethylation of the H19 gene causes not only Silver\u2013Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am. J. Hum. Genet. 78, 604\u2013614 https:\/\/doi.org\/10.1086\/502981 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"1303_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060105","volume":"8","author":"T Fuke","year":"2013","unstructured":"Fuke, T. et al. Molecular and clinical studies in 138 Japanese patients with Silver\u2013Russell syndrome. PLoS ONE\u00a08, e60105 https:\/\/doi.org\/10.1371\/journal.pone.0060105 (2013).","journal-title":"PLoS ONE"},{"key":"1303_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1210\/endrev\/bnad002","volume":"44","author":"ACS Hokken-Koelega","year":"2023","unstructured":"Hokken-Koelega, A. C. S. et al. International consensus guideline on small for gestational age: etiology and management from infancy to early adulthood. Endocr. Rev. 44, 539\u2013565 https:\/\/doi.org\/10.1210\/endrev\/bnad002 (2023).","journal-title":"Endocr. Rev."},{"key":"1303_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/gim.2017.53","volume":"19","author":"M Kagami","year":"2017","unstructured":"Kagami, M. et al. Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients. Genet. Med. 19, 1356\u20131366 https:\/\/doi.org\/10.1038\/gim.2017.53 (2017).","journal-title":"Genet. Med."},{"key":"1303_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ejhg.2017.91","volume":"25","author":"J Beygo","year":"2017","unstructured":"Beygo, J. et al. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome. Eur. J. Hum. Genet. 25, 935\u2013945 https:\/\/doi.org\/10.1038\/ejhg.2017.91 (2017).","journal-title":"Eur. J. Hum. Genet."},{"key":"1303_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajmg.a.38533","volume":"176","author":"A Lande","year":"2018","unstructured":"Lande, A., Kroken, M., Rabben, K. & Retterstol, L. Temple syndrome as a differential diagnosis to Prader\u2013Willi syndrome: identifying three new patients. Am. J. Med. Genet. A 176, 175\u2013180 https:\/\/doi.org\/10.1002\/ajmg.a.38533 (2018).","journal-title":"Am. J. Med. Genet. A"},{"key":"1303_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau9425","volume":"5","author":"W Abi Habib","year":"2019","unstructured":"Abi Habib, W. et al. Transcriptional profiling at the DLK1\/MEG3 domain explains clinical overlap between imprinting disorders. Sci. Adv. 5, eaau9425 https:\/\/doi.org\/10.1126\/sciadv.aau9425 (2019).","journal-title":"Sci. Adv."},{"key":"1303_CR28","doi-asserted-by":"publisher","first-page":"e3041","DOI":"10.1210\/clinem\/dgae883","volume":"110","author":"T Ogawa","year":"2025","unstructured":"Ogawa, T. et al. Temple syndrome: comprehensive clinical study in genetically confirmed 60 Japanese patients. J. Clin. Endocrinol. Metab. 110, e3041\u2013e3051 https:\/\/doi.org\/10.1210\/clinem\/dgae883 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR29","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1210\/jc.2017-02152","volume":"103","author":"S Geoffron","year":"2018","unstructured":"Geoffron, S. et al. Chromosome 14q32.2 imprinted region disruption as an alternative molecular diagnosis of Silver\u2013Russell syndrome. J. Clin. Endocrinol. Metab. 103, 2436\u20132446 https:\/\/doi.org\/10.1210\/jc.2017-02152 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/cge.13244","volume":"93","author":"G Gillessen-Kaesbach","year":"2018","unstructured":"Gillessen-Kaesbach, G. et al. Molecular and clinical studies in 8 patients with Temple syndrome. Clin. Genet. 93, 1179\u20131188 https:\/\/doi.org\/10.1111\/cge.13244 (2018).","journal-title":"Clin. Genet."},{"key":"1303_CR31","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.3390\/jcm11216289","volume":"11","author":"AF Juriaans","year":"2022","unstructured":"Juriaans, A. F. et al. Temple syndrome: clinical findings, body composition and cognition in 15 patients. J. Clin. Med. 11, 6289\u20136300 https:\/\/doi.org\/10.3390\/jcm11216289 (2022).","journal-title":"J. Clin. Med."},{"key":"1303_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1056\/NEJMoa1415227","volume":"373","author":"M Begemann","year":"2015","unstructured":"Begemann, M. et al. Paternally inherited IGF2 mutation and growth restriction. N. Engl. J. Med. 373, 349\u2013356 https:\/\/doi.org\/10.1056\/NEJMoa1415227 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1303_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/jmedgenet-2013-101691","volume":"50","author":"F Brioude","year":"2013","unstructured":"Brioude, F. et al. CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. J. Med. Genet. 50, 823\u2013830 https:\/\/doi.org\/10.1136\/jmedgenet-2013-101691 (2013).","journal-title":"J. Med. Genet."},{"key":"1303_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1398250","volume":"2019","author":"AH Sabir","year":"2019","unstructured":"Sabir, A. H. et al. Familial Russell\u2013Silver syndrome like phenotype in the PCNA domain of the CDKN1C gene, a further case. Case Rep. Genet. 2019, 1398250 https:\/\/doi.org\/10.1155\/2019\/1398250 (2019).","journal-title":"Case Rep. Genet."},{"key":"1303_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/gim.2017.105","volume":"20","author":"W Abi Habib","year":"2018","unstructured":"Abi Habib, W. et al. Genetic disruption of the oncogenic HMGA2\u2013PLAG1\u2013IGF2 pathway causes fetal growth restriction. Genet. Med. 20, 250\u2013258 https:\/\/doi.org\/10.1038\/gim.2017.105 (2018).","journal-title":"Genet. Med."},{"key":"1303_CR36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/cge.13727","volume":"97","author":"TD Hjortshoj","year":"2020","unstructured":"Hjortshoj, T. D. et al. upd(20)mat is a rare cause of the Silver\u2013Russell-syndrome-like phenotype: two unrelated cases and screening of large cohorts. Clin. Genet. 97, 902\u2013907 https:\/\/doi.org\/10.1111\/cge.13727 (2020).","journal-title":"Clin. Genet."},{"key":"1303_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/genes12040588","volume":"12","author":"P Tannorella","year":"2021","unstructured":"Tannorella, P. et al. Maternal uniparental disomy of chromosome 20 (UPD(20)mat) as differential diagnosis of Silver Russell syndrome: identification of three new cases. Genes 12, 588\u2013598 https:\/\/doi.org\/10.3390\/genes12040588 (2021).","journal-title":"Genes"},{"key":"1303_CR38","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1210\/jc.2017-02780","volume":"103","author":"S Kawashima","year":"2018","unstructured":"Kawashima, S. et al. Maternal uniparental disomy for chromosome 20: physical and endocrinological characteristics of five patients. J. Clin. Endocrinol. Metab. 103, 2083\u20132088 https:\/\/doi.org\/10.1210\/jc.2017-02780 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/humu.22623","volume":"35","author":"S Azzi","year":"2014","unstructured":"Azzi, S. et al. Complex tissue-specific epigenotypes in Russell\u2013Silver syndrome associated with 11p15 ICR1 hypomethylation. Hum. Mutat. 35, 1211\u20131220 https:\/\/doi.org\/10.1002\/humu.22623 (2014).","journal-title":"Hum. Mutat."},{"key":"1303_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01713-y","volume":"16","author":"DJG Mackay","year":"2024","unstructured":"Mackay, D. J. G. et al. Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis. Clin. Epigenetics 16, 99 https:\/\/doi.org\/10.1186\/s13148-024-01713-y (2024).","journal-title":"Clin. Epigenetics"},{"key":"1303_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01683-x","volume":"16","author":"R Meyer","year":"2021","unstructured":"Meyer, R. et al. One test for all: whole exome sequencing significantly improves the diagnostic yield in growth retarded patients referred for molecular testing for Silver\u2013Russell syndrome. Orphanet J. Rare Dis. 16, 42 https:\/\/doi.org\/10.1186\/s13023-021-01683-x (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"1303_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01358-9","volume":"14","author":"D Mackay","year":"2022","unstructured":"Mackay, D. et al. First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders. Clin. Epigenetics 14, 143 https:\/\/doi.org\/10.1186\/s13148-022-01358-9 (2022).","journal-title":"Clin. Epigenetics"},{"key":"1303_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000452082","volume":"8","author":"C Cunniff","year":"2017","unstructured":"Cunniff, C., Bassetti, J. A. & Ellis, N. A. Bloom\u2019s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition. Mol. Syndromol. 8, 4\u201323 https:\/\/doi.org\/10.1159\/000452082 (2017).","journal-title":"Mol. Syndromol."},{"key":"1303_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/ng.2275","volume":"44","author":"VA Arboleda","year":"2012","unstructured":"Arboleda, V. A. et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat. Genet. 44, 788\u2013792 https:\/\/doi.org\/10.1038\/ng.2275 (2012).","journal-title":"Nat. Genet."},{"key":"1303_CR45","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cen.12379","volume":"80","author":"F Kato","year":"2014","unstructured":"Kato, F. et al. IMAGe syndrome: clinical and genetic implications based on investigations in three Japanese patients. Clin. Endocrinol. 80, 706\u2013713 https:\/\/doi.org\/10.1111\/cen.12379 (2014).","journal-title":"Clin. Endocrinol."},{"key":"1303_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.953707","volume":"13","author":"JP Suntharalingham","year":"2022","unstructured":"Suntharalingham, J. P. et al. Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome. Front. Endocrinol. 13, 953707 https:\/\/doi.org\/10.3389\/fendo.2022.953707 (2022).","journal-title":"Front. Endocrinol."},{"key":"1303_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/15592294.2016.1264561","volume":"13","author":"D Monk","year":"2018","unstructured":"Monk, D. et al. Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains. Epigenetics 13, 117\u2013121 https:\/\/doi.org\/10.1080\/15592294.2016.1264561 (2018).","journal-title":"Epigenetics"},{"key":"1303_CR48","doi-asserted-by":"publisher","first-page":"e929","DOI":"10.1542\/peds.2008-3228","volume":"123","author":"T Eggermann","year":"2009","unstructured":"Eggermann, T. et al. Broad clinical spectrum in Silver\u2013Russell syndrome and consequences for genetic testing in growth retardation. Pediatrics 123, e929\u2013e931 https:\/\/doi.org\/10.1542\/peds.2008-3228 (2009).","journal-title":"Pediatrics"},{"key":"1303_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/jmg.2007.053207","volume":"45","author":"RH Scott","year":"2008","unstructured":"Scott, R. H. et al. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. J. Med. Genet. 45, 106\u2013113 https:\/\/doi.org\/10.1136\/jmg.2007.053207 (2008).","journal-title":"J. Med. Genet."},{"key":"1303_CR50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1399-0004.2011.01822.x","volume":"81","author":"J Demars","year":"2012","unstructured":"Demars, J. & Gicquel, C. Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith\u2013Wiedemann and Silver\u2013Russell syndromes. Clin. Genet. 81, 350\u2013361 https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01822.x (2012).","journal-title":"Clin. Genet."},{"key":"1303_CR51","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1586\/erm.12.43","volume":"12","author":"T Eggermann","year":"2012","unstructured":"Eggermann, T., Spengler, S., Gogiel, M., Begemann, M. & Elbracht, M. Epigenetic and genetic diagnosis of Silver\u2013Russell syndrome. Expert Rev. Mol. Diagn. 12, 459\u2013471 https:\/\/doi.org\/10.1586\/erm.12.43 (2012).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"1303_CR52","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng1629","volume":"37","author":"C Gicquel","year":"2005","unstructured":"Gicquel, C. et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver\u2013Russell syndrome. Nat. Genet. 37, 1003\u20131007 https:\/\/doi.org\/10.1038\/ng1629 (2005).","journal-title":"Nat. Genet."},{"key":"1303_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1399-0004.2010.01514.x","volume":"80","author":"M Begemann","year":"2011","unstructured":"Begemann, M. et al. Silver\u2013Russell patients showing a broad range of ICR1 and ICR2 hypomethylation in different tissues. Clin. Genet. 80, 83\u201388 https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01514.x (2011).","journal-title":"Clin. Genet."},{"key":"1303_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0183-8","volume":"8","author":"S Russo","year":"2016","unstructured":"Russo, S. et al. A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver\u2013Russell and Beckwith\u2013Wiedemann syndromes. Clin. Epigenetics 8, 23 https:\/\/doi.org\/10.1186\/s13148-016-0183-8 (2016).","journal-title":"Clin. Epigenetics"},{"key":"1303_CR55","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/jmedgenet-2012-100967","volume":"49","author":"M Begemann","year":"2012","unstructured":"Begemann, M. et al. Clinical significance of copy number variations in the 11p15.5 imprinting control regions: new cases and review of the literature. J. Med. Genet. 49, 547\u2013553 https:\/\/doi.org\/10.1136\/jmedgenet-2012-100967 (2012).","journal-title":"J. Med. Genet."},{"key":"1303_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/jmedgenet-2017-104919","volume":"55","author":"S Heide","year":"2018","unstructured":"Heide, S. et al. Chromosomal rearrangements in the 11p15 imprinted region: 17 new 11p15.5 duplications with associated phenotypes and putative functional consequences. J. Med. Genet. 55, 205\u2013213 https:\/\/doi.org\/10.1136\/jmedgenet-2017-104919 (2018).","journal-title":"J. Med. Genet."},{"key":"1303_CR57","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jmg.2007.057059","volume":"45","author":"H Bullman","year":"2008","unstructured":"Bullman, H. et al. Mosaic maternal uniparental disomy of chromosome 11 in a patient with Silver\u2013Russell syndrome. J. Med. Genet. 45, 396\u2013399 https:\/\/doi.org\/10.1136\/jmg.2007.057059 (2008).","journal-title":"J. Med. Genet."},{"key":"1303_CR58","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/ajmg.a.37679","volume":"170","author":"HM Luk","year":"2016","unstructured":"Luk, H. M. et al. Silver\u2013Russell syndrome in a patient with somatic mosaicism for upd(11)mat identified by buccal cell analysis. Am. J. Med. Genet. A 170, 1938\u20131941 https:\/\/doi.org\/10.1002\/ajmg.a.37679 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"1303_CR59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/genes12040581","volume":"12","author":"L Pignata","year":"2021","unstructured":"Pignata, L. et al. Mosaicsegmental and whole-chromosome upd(11)mat in Silver\u2013Russell syndrome. Genes 12, 581\u2013590 https:\/\/doi.org\/10.3390\/genes12040581 (2021).","journal-title":"Genes"},{"key":"1303_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jmg.34.1.6","volume":"34","author":"MA Preece","year":"1997","unstructured":"Preece, M. A. et al. Maternal uniparental disomy 7 in Silver\u2013Russell syndrome. J. Med. Genet. 34, 6\u20139 (1997).","journal-title":"J. Med. Genet."},{"key":"1303_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-025-01867-3","volume":"17","author":"M Begemann","year":"2025","unstructured":"Begemann, M. et al. Maternal uniparental disomy of chromosome 7: how chromosome 7-encoded imprinted genes contribute to the Silver\u2013Russell phenotype. Clin. Epigenetics 17, 70 https:\/\/doi.org\/10.1186\/s13148-025-01867-3 (2025).","journal-title":"Clin. Epigenetics"},{"key":"1303_CR62","first-page":"217","volume":"42","author":"JE Spence","year":"1988","unstructured":"Spence, J. E. et al. Uniparental disomy as a mechanism for human genetic disease. Am. J. Hum. Genet. 42, 217\u2013226 (1988).","journal-title":"Am. J. Hum. Genet."},{"key":"1303_CR63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/ng.2007.56","volume":"40","author":"M Kagami","year":"2008","unstructured":"Kagami, M. et al. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat. Genet. 40, 237\u2013242 https:\/\/doi.org\/10.1038\/ng.2007.56 (2008).","journal-title":"Nat. Genet."},{"key":"1303_CR64","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/jmg.28.8.511","volume":"28","author":"IK Temple","year":"1991","unstructured":"Temple, I. K., Cockwell, A., Hassold, T., Pettay, D. & Jacobs, P. Maternal uniparental disomy for chromosome 14. J. Med. Genet. 28, 511\u2013514 https:\/\/doi.org\/10.1136\/jmg.28.8.511 (1991).","journal-title":"J. Med. Genet."},{"key":"1303_CR65","doi-asserted-by":"publisher","DOI":"10.1017\/S001667231900003X","volume":"101","author":"DJG Mackay","year":"2019","unstructured":"Mackay, D. J. G. et al. Discrepant molecular and clinical diagnoses in Beckwith\u2013Wiedemann and Silver\u2013Russell syndromes. Genet. Res. 101, e3 https:\/\/doi.org\/10.1017\/S001667231900003X (2019).","journal-title":"Genet. Res."},{"key":"1303_CR66","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/genes13101875","volume":"13","author":"F Passaretti","year":"2022","unstructured":"Passaretti, F. et al. Different mechanisms cause hypomethylation of both H19 and KCNQ1OT1 imprinted differentially methylated regions in two cases of Silver\u2013Russell syndrome spectrum. Genes 13, 1875\u20131886 https:\/\/doi.org\/10.3390\/genes13101875 (2022).","journal-title":"Genes"},{"key":"1303_CR67","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/ejhg.2016.45","volume":"24","author":"K Eggermann","year":"2016","unstructured":"Eggermann, K. et al. EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver\u2013Russell and Beckwith\u2013Wiedemann syndrome. Eur. J. Hum. Genet. 24, 1377\u20131387 https:\/\/doi.org\/10.1038\/ejhg.2016.45 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"1303_CR68","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/pd.6398","volume":"43","author":"J Beygo","year":"2023","unstructured":"Beygo, J. et al. Prenatal testing for imprinting disorders: a laboratory perspective. Prenat. Diagn. 43, 973\u2013982 https:\/\/doi.org\/10.1002\/pd.6398 (2023).","journal-title":"Prenat. Diagn."},{"key":"1303_CR69","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1136\/bmj.3.5826.566","volume":"3","author":"JC Waterlow","year":"1972","unstructured":"Waterlow, J. C. Classification and definition of protein-calorie malnutrition. Br. Med. J. 3, 566\u2013569 https:\/\/doi.org\/10.1136\/bmj.3.5826.566 (1972).","journal-title":"Br. Med. J."},{"key":"1303_CR70","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/archdischild-2013-305864","volume":"100","author":"C Marsaud","year":"2015","unstructured":"Marsaud, C., Rossignol, S., Tounian, P., Netchine, I. & Dubern, B. Prevalence and management of gastrointestinal manifestations in Silver\u2013Russell syndrome. Arch. Dis. Child. 100, 353\u2013358 https:\/\/doi.org\/10.1136\/archdischild-2013-305864 (2015).","journal-title":"Arch. Dis. Child."},{"key":"1303_CR71","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/080352500750043927","volume":"89","author":"J Blissett","year":"2000","unstructured":"Blissett, J., Harris, G. & Kirk, J. Effect of growth hormone therapy on feeding problems and food intake in children with growth disorders. Acta Paediatr. 89, 644\u2013649 https:\/\/doi.org\/10.1080\/080352500750043927 (2000).","journal-title":"Acta Paediatr."},{"key":"1303_CR72","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1515\/jpem.2005.18.7.651","volume":"18","author":"A Christoforidis","year":"2005","unstructured":"Christoforidis, A., Maniadaki, I. & Stanhope, R. Managing children with Russell-Silver syndrome: more than just growth hormone treatment? J. Pediatr. Endocrinol. Metab. 18, 651\u2013652 https:\/\/doi.org\/10.1515\/jpem.2005.18.7.651 (2005).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1303_CR73","doi-asserted-by":"publisher","first-page":"e900","DOI":"10.1210\/clinem\/dgaf452","volume":"111","author":"E Giabicani","year":"2026","unstructured":"Giabicani, E. et al. Early growth hormone treatment enhances growth and nutritional status in Silver\u2013Russell syndrome. J. Clin. Endocrinol. Metab. 111, e900\u2013e907 https:\/\/doi.org\/10.1210\/clinem\/dgaf452 (2026).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1203\/01.PDR.0000169980.35179.89","volume":"58","author":"N Ezzahir","year":"2005","unstructured":"Ezzahir, N. et al. Time course of catch-up in adiposity influences adult anthropometry in individuals who were born small for gestational age. Pediatr. Res. 58, 243\u2013247 https:\/\/doi.org\/10.1203\/01.PDR.0000169980.35179.89 (2005).","journal-title":"Pediatr. Res."},{"key":"1303_CR75","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1001\/jama.2009.761","volume":"301","author":"RW Leunissen","year":"2009","unstructured":"Leunissen, R. W., Kerkhof, G. F., Stijnen, T. & Hokken-Koelega, A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 301, 2234\u20132242 https:\/\/doi.org\/10.1001\/jama.2009.761 (2009).","journal-title":"JAMA"},{"key":"1303_CR76","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1159\/000338791","volume":"77","author":"RW Leunissen","year":"2012","unstructured":"Leunissen, R. W., Kerkhof, G. F., Stijnen, T. & Hokken-Koelega, A. C. Effect of birth size and catch-up growth on adult blood pressure and carotid intima-media thickness. Horm. Res. Paediatr. 77, 394\u2013401 https:\/\/doi.org\/10.1159\/000338791 (2012).","journal-title":"Horm. Res. Paediatr."},{"key":"1303_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/EJE-21-1130","volume":"187","author":"WJ Goedegebuure","year":"2022","unstructured":"Goedegebuure, W. J., Van der Steen, M., Smeets, C. C. J., Kerkhof, G. F. & Hokken-Koelega, A. C. S. SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years. Eur. J. Endocrinol. 187, 15\u201326 https:\/\/doi.org\/10.1530\/EJE-21-1130 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"1303_CR78","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/BF01958638","volume":"154","author":"HA Wollmann","year":"1995","unstructured":"Wollmann, H. A., Kirchner, T., Enders, H., Preece, M. A. & Ranke, M. B. Growth and symptoms in Silver\u2013Russell syndrome: review on the basis of 386 patients. Eur. J. Pediatr. 154, 958\u2013968 (1995).","journal-title":"Eur. J. Pediatr."},{"key":"1303_CR79","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2223\/JPED.2174","volume":"88","author":"M Epifanio","year":"2012","unstructured":"Epifanio, M. et al. A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis. J. Pediatr. 88, 155\u2013160 https:\/\/doi.org\/10.2223\/JPED.2174 (2012).","journal-title":"J. Pediatr."},{"key":"1303_CR80","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.appet.2019.02.012","volume":"137","author":"ME Harrison","year":"2019","unstructured":"Harrison, M. E. et al. Use of cyproheptadine to stimulate appetite and body weight gain: a systematic review. Appetite 137, 62\u201372 https:\/\/doi.org\/10.1016\/j.appet.2019.02.012 (2019).","journal-title":"Appetite"},{"key":"1303_CR81","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.clinthera.2021.08.001","volume":"43","author":"SY Kim","year":"2021","unstructured":"Kim, S. Y. et al. Efficacy and tolerability of cyproheptadine in poor appetite: a multicenter, randomized, double-blind, placebo-controlled study. Clin. Ther. 43, 1757\u20131772 https:\/\/doi.org\/10.1016\/j.clinthera.2021.08.001 (2021).","journal-title":"Clin. Ther."},{"key":"1303_CR82","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/MPG.0000000000001708","volume":"66","author":"A Lemoine","year":"2018","unstructured":"Lemoine, A. et al. Effect of cyproheptadine on weight and growth velocity in children with Silver\u2013Russell syndrome. J. Pediatr. Gastroenterol. Nutr. 66, 306\u2013311 https:\/\/doi.org\/10.1097\/MPG.0000000000001708 (2018).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"1303_CR83","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/apa.17474","volume":"114","author":"N Muz","year":"2025","unstructured":"Muz, N., Petersson, M., Saalman, R. & Dahlgren, J. Percutaneous endoscopic gastrostomy helped to normalise feeding problems and gastrointestinal symptoms in Silver\u2013Russell syndrome. Acta Paediatr. 114, 569\u2013577 https:\/\/doi.org\/10.1111\/apa.17474 (2025).","journal-title":"Acta Paediatr."},{"key":"1303_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ajmg.10667","volume":"113","author":"J Anderson","year":"2002","unstructured":"Anderson, J., Viskochil, D., O\u2019Gorman, M. & Gonzales, C. Gastrointestinal complications of Russell\u2013Silver syndrome: a pilot study. Am. J. Med. Genet. 113, 15\u201319 https:\/\/doi.org\/10.1002\/ajmg.10667 (2002).","journal-title":"Am. J. Med. Genet."},{"key":"1303_CR85","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1515\/JPEM.2005.18.7.663","volume":"18","author":"C Azcona","year":"2005","unstructured":"Azcona, C. & Stanhope, R. Hypoglycaemia and Russell\u2013Silver syndrome. J. Pediatr. Endocrinol. Metab. 18, 663\u2013670 (2005).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1303_CR86","first-page":"275","volume":"103","author":"AC O\u2019Connell","year":"2010","unstructured":"O\u2019Connell, A. C., O\u2019Connell, S. M., O\u2019Mullane, E. & Hoey, H. M. Oral health of children born small for gestational age. Ir. Med. J. 103, 275\u2013278 (2010).","journal-title":"Ir. Med. J."},{"key":"1303_CR87","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000090376","volume":"65","author":"VH Boonstra","year":"2006","unstructured":"Boonstra, V. H. et al. Food intake of children with short stature born small for gestational age before and during a randomized GH trial. Horm. Res. 65, 23\u201330 https:\/\/doi.org\/10.1159\/000090376 (2006).","journal-title":"Horm. Res."},{"key":"1303_CR88","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/diagnostics11050749","volume":"11","author":"SC Grunert","year":"2021","unstructured":"Grunert, S. C. et al. Isolated hypomethylation of IGF2 associated with severe hypoglycemia responsive to growth hormone treatment. Diagnostics 11, 749\u2013754 https:\/\/doi.org\/10.3390\/diagnostics11050749 (2021).","journal-title":"Diagnostics"},{"key":"1303_CR89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0884533615622639","volume":"31","author":"NL Canada","year":"2016","unstructured":"Canada, N. L., Mullins, L., Pearo, B. & Spoede, E. Optimizing perioperative nutrition in pediatric populations. Nutr. Clin. Pract. 31, 49\u201358 https:\/\/doi.org\/10.1177\/0884533615622639 (2016).","journal-title":"Nutr. Clin. Pract."},{"key":"1303_CR90","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1213\/00000539-199406000-00035","volume":"78","author":"M Dinner","year":"1994","unstructured":"Dinner, M., Goldin, E. Z., Ward, R. & Levy, J. Russell\u2013Silver syndrome: anesthetic implications. Anesth. Analg. 78, 1197\u20131199 https:\/\/doi.org\/10.1213\/00000539-199406000-00035 (1994).","journal-title":"Anesth. Analg."},{"key":"1303_CR91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ajmg.1320560223","volume":"56","author":"J Kotilainen","year":"1995","unstructured":"Kotilainen, J. et al. Craniofacial and dental characteristics of Silver\u2013Russell syndrome. Am. J. Med. Genet. 56, 229\u2013236 https:\/\/doi.org\/10.1002\/ajmg.1320560223 (1995).","journal-title":"Am. J. Med. Genet."},{"key":"1303_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s40981-024-00704-5","volume":"10","author":"A Hibino","year":"2024","unstructured":"Hibino, A., Hibino, A. & Kamiya, Y. Anesthesia experience in an adult Silver\u2013Russell syndrome: a case report. JA Clin. Rep. 10, 20 https:\/\/doi.org\/10.1186\/s40981-024-00704-5 (2024).","journal-title":"JA Clin. Rep."},{"key":"1303_CR93","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cen.14715","volume":"97","author":"O Lokulo-Sodipe","year":"2022","unstructured":"Lokulo-Sodipe, O. et al. Height and body mass index in molecularly confirmed Silver\u2013Russell syndrome and the long-term effects of growth hormone treatment. Clin. Endocrinol. 97, 284\u2013292 https:\/\/doi.org\/10.1111\/cen.14715 (2022).","journal-title":"Clin. Endocrinol."},{"key":"1303_CR94","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1210\/jc.2002-021172","volume":"88","author":"Y Van Pareren","year":"2003","unstructured":"Van Pareren, Y. et al. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J. Clin. Endocrinol. Metab. 88, 3584\u20133590 https:\/\/doi.org\/10.1210\/jc.2002-021172 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR95","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1203\/01.PDR.0000148716.71231.81","volume":"57","author":"J Dahlgren","year":"2005","unstructured":"Dahlgren, J., Wikland, K. A. & Swedish Study Group for Growth Hormone Treatment. Final height in short children born small for gestational age treated with growth hormone. Pediatr. Res. 57, 216\u2013222 https:\/\/doi.org\/10.1203\/01.PDR.0000148716.71231.81 (2005).","journal-title":"Pediatr. Res."},{"key":"1303_CR96","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5603\/EP.a2023.0042","volume":"74","author":"A Swiader-Lesniak","year":"2023","unstructured":"Swiader-Lesniak, A. et al. The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver\u2013Russell syndrome. Endokrynol. Pol. 74, 285\u2013293 https:\/\/doi.org\/10.5603\/EP.a2023.0042 (2023).","journal-title":"Endokrynol. Pol."},{"key":"1303_CR97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000354658","volume":"80","author":"G Binder","year":"2013","unstructured":"Binder, G. et al. Adult height and epigenotype in children with Silver\u2013Russell syndrome treated with GH. Horm. Res. Paediatr. 80, 193\u2013200 https:\/\/doi.org\/10.1159\/000354658 (2013).","journal-title":"Horm. Res. Paediatr."},{"key":"1303_CR98","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/ejendo\/lvag021","volume":"194","author":"A Linglart","year":"2026","unstructured":"Linglart, A. et al. Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial. Eur. J. Endocrinol. 194, 311\u2013325 https:\/\/doi.org\/10.1093\/ejendo\/lvag021 (2026).","journal-title":"Eur. J. Endocrinol."},{"key":"1303_CR99","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2265.2007.02913.x","volume":"67","author":"RH Willemsen","year":"2007","unstructured":"Willemsen, R. H. et al. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. Clin. Endocrinol. 67, 485\u2013492 https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02913.x (2007).","journal-title":"Clin. Endocrinol."},{"key":"1303_CR100","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1210\/jc.2007-2600","volume":"93","author":"R Schweizer","year":"2008","unstructured":"Schweizer, R., Martin, D. D., Schonau, E. & Ranke, M. B. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition. J. Clin. Endocrinol. Metab. 93, 2978\u20132983 https:\/\/doi.org\/10.1210\/jc.2007-2600 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR101","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/jcm11092496","volume":"11","author":"LN Grootjen","year":"2022","unstructured":"Grootjen, L. N. et al. Long-term growth hormone treatment of children with PWS: the earlier the start, the better the outcomes? J. Clin. Med. 11, 2496\u20132507 https:\/\/doi.org\/10.3390\/jcm11092496 (2022).","journal-title":"J. Clin. Med."},{"key":"1303_CR102","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-15-0873","volume":"174","author":"DB Allen","year":"2016","unstructured":"Allen, D. B. et al. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur. J. Endocrinol. 174, P1\u2013P9 https:\/\/doi.org\/10.1530\/EJE-15-0873 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"1303_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502231","volume":"92","author":"PF Collett-Solberg","year":"2019","unstructured":"Collett-Solberg, P. F. et al. Diagnosis, genetics, and therapy of short stature in children: a Growth Hormone Research Society international perspective. Horm. Res. Paediatr. 92, 1\u201314 https:\/\/doi.org\/10.1159\/000502231 (2019).","journal-title":"Horm. Res. Paediatr."},{"key":"1303_CR104","doi-asserted-by":"publisher","first-page":"e1291","DOI":"10.1210\/clinem\/dgz118","volume":"105","author":"MG Wegmann","year":"2020","unstructured":"Wegmann, M. G. et al. Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA. J. Clin. Endocrinol. Metab. 105, e1291\u2013e1298 https:\/\/doi.org\/10.1210\/clinem\/dgz118 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR105","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1210\/clinem\/dgae616","volume":"110","author":"A Juul","year":"2025","unstructured":"Juul, A. et al. Somapacitan in children born SGA: 52-week efficacy, safety, and IGF-I response results from the phase 2 REAL5 study. J. Clin. Endocrinol. Metab. 110, 1086\u20131095 https:\/\/doi.org\/10.1210\/clinem\/dgae616 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR106","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1210\/jc.2015-1410","volume":"100","author":"NE Bakker","year":"2015","unstructured":"Bakker, N. E., van Doorn, J., Renes, J. S., Donker, G. H. & Hokken-Koelega, A. C. IGF-1 levels, complex formation, and IGF bioactivity in growth hormone-treated children with Prader\u2013Willi syndrome. J. Clin. Endocrinol. Metab. 100, 3041\u20133049 https:\/\/doi.org\/10.1210\/jc.2015-1410 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR107","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1210\/clinem\/dgac605","volume":"108","author":"ASL Kjaer","year":"2023","unstructured":"Kjaer, A. S. L. et al. Tracking and cumulative lifetime exposure to IGF-I in 6459 healthy individuals and in SGA children treated with GH. J. Clin. Endocrinol. Metab. 108, 642\u2013652 https:\/\/doi.org\/10.1210\/clinem\/dgac605 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR108","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1297\/cpe.29.159","volume":"29","author":"R Horikawa","year":"2020","unstructured":"Horikawa, R., Tanaka, T., Nishinaga, H., Nishiba, Y. & Yokoya, S. The long-term safety and effectiveness of growth hormone treatment in Japanese children with short stature born small for gestational age. Clin. Pediatr. Endocrinol. 29, 159\u2013171 https:\/\/doi.org\/10.1297\/cpe.29.159 (2020).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"1303_CR109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S2352-4642(22)00240-1","volume":"6","author":"WJ Goedegebuure","year":"2022","unstructured":"Goedegebuure, W. J., van der Steen, M., Smeets, C. C. J. & Hokken-Koelega, A. C. S. Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study. Lancet Child. Adolesc. Health 6, 777\u2013787 https:\/\/doi.org\/10.1016\/S2352-4642(22)00240-1 (2022).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"1303_CR110","first-page":"463","volume":"17","author":"AC Hokken-Koelega","year":"2004","unstructured":"Hokken-Koelega, A. C., De Waal, W. J., Sas, T. C., Van Pareren, Y. & Arends, N. J. Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment. J. Pediatr. Endocrinol. Metab. 17, 463\u2013469 (2004).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1303_CR111","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1210\/jc.2015-2619","volume":"100","author":"M van der Steen","year":"2015","unstructured":"van der Steen, M. et al. Metabolic health in short children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analog: results of a randomized, dose-response trial. J. Clin. Endocrinol. Metab. 100, 3725\u20133734 https:\/\/doi.org\/10.1210\/jc.2015-2619 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR112","doi-asserted-by":"publisher","first-page":"e2796","DOI":"10.1210\/clinem\/dgaa287","volume":"105","author":"WJ Goedegebuure","year":"2020","unstructured":"Goedegebuure, W. J., van der Steen, M., Kerkhof, G. F. & Hokken-Koelega, A. C. S. Longitudinal study on metabolic health in adults SGA during 5 years after GH with or without 2 years of GnRHa treatment. J. Clin. Endocrinol. Metab. 105, e2796\u2013e2806 https:\/\/doi.org\/10.1210\/clinem\/dgaa287 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR113","doi-asserted-by":"publisher","first-page":"e1185","DOI":"10.1210\/clinem\/dgad622","volume":"109","author":"DJ Dorrepaal","year":"2024","unstructured":"Dorrepaal, D. J. et al. Cerebrovascular abnormalities in adults born SGA at 12 years after growth hormone cessation compared to controls. J. Clin. Endocrinol. Metab. 109, e1185\u2013e1193 https:\/\/doi.org\/10.1210\/clinem\/dgad622 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR114","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.2003-031848","volume":"89","author":"KK Ong","year":"2004","unstructured":"Ong, K. K. et al. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J. Clin. Endocrinol. Metab. 89, 2647\u20132651 https:\/\/doi.org\/10.1210\/jc.2003-031848 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR115","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1210\/jc.2017-00874","volume":"102","author":"G Binder","year":"2017","unstructured":"Binder, G., Schweizer, R., Blumenstock, G. & Ferrand, N. Adrenarche in Silver\u2013Russell syndrome: timing and consequences. J. Clin. Endocrinol. Metab. 102, 4100\u20134108 https:\/\/doi.org\/10.1210\/jc.2017-00874 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.975511","volume":"13","author":"G Patti","year":"2022","unstructured":"Patti, G. et al. Pubertal timing in children with Silver Russell syndrome compared to those born small for gestational age. Front. Endocrinol. 13, 975511 https:\/\/doi.org\/10.3389\/fendo.2022.975511 (2022).","journal-title":"Front. Endocrinol."},{"key":"1303_CR117","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/humrep\/dey286","volume":"33","author":"WJ Goedegebuure","year":"2018","unstructured":"Goedegebuure, W. J., Smeets, C. C. J., Renes, J. S., de Rijke, Y. B. & Hokken-Koelega, A. C. S. Gonadal function and pubertal development in patients with Silver\u2013Russell syndrome. Hum. Reprod. 33, 2122\u20132130 https:\/\/doi.org\/10.1093\/humrep\/dey286 (2018).","journal-title":"Hum. Reprod."},{"key":"1303_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00829","volume":"10","author":"K Kvernebo Sunnergren","year":"2019","unstructured":"Kvernebo Sunnergren, K., Ankarberg-Lindgren, C. & Dahlgren, J. Adrenal and gonadal activity, androgen concentrations, and adult height outcomes in boys with Silver\u2013Russell syndrome. Front. Endocrinol. 10, 829 https:\/\/doi.org\/10.3389\/fendo.2019.00829 (2019).","journal-title":"Front. Endocrinol."},{"key":"1303_CR119","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrendo.2011.161","volume":"8","author":"JM Wit","year":"2011","unstructured":"Wit, J. M., Hero, M. & Nunez, S. B. Aromatase inhibitors in pediatrics. Nat. Rev. Endocrinol. 8, 135\u2013147 https:\/\/doi.org\/10.1038\/nrendo.2011.161 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1303_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnac014","volume":"44","author":"N Mauras","year":"2023","unstructured":"Mauras, N., Ross, J. & Mericq, V. Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical review. Endocr. Rev. 44, 1\u201313 https:\/\/doi.org\/10.1210\/endrev\/bnac014 (2023).","journal-title":"Endocr. Rev."},{"key":"1303_CR121","doi-asserted-by":"publisher","first-page":"e2871","DOI":"10.1210\/clinem\/dgaf271","volume":"110","author":"Y Cui","year":"2025","unstructured":"Cui, Y., Zhang, Q., Hou, L. & Luo, X. The combination of aromatase inhibitors and GH treatment for idiopathic short stature in male adolescents. J. Clin. Endocrinol. Metab. 110, e2871\u2013e2877 https:\/\/doi.org\/10.1210\/clinem\/dgaf271 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00780","volume":"9","author":"K Kvernebo-Sunnergren","year":"2018","unstructured":"Kvernebo-Sunnergren, K. et al. Hyperestrogenism affects adult height outcome in growth hormone treated boys with Silver\u2013Russell syndrome. Front. Endocrinol. 9, 780 https:\/\/doi.org\/10.3389\/fendo.2018.00780 (2018).","journal-title":"Front. Endocrinol."},{"issue":"Suppl 1","key":"1303_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000525242","volume":"95","author":"MN Dufourg","year":"2022","unstructured":"Dufourg, M. N. et al. Aromatase Inhibitor (anastrazole) versus placebo delays bone age maturation in prepubertal children with Silver Russell or Prader\u2013Willi syndrome and pathological adrenarche [abstract]. Horm. Res. Paediatr. 95(Suppl 1), 1\u2013266 https:\/\/doi.org\/10.1159\/000525242 (2022).","journal-title":"Horm. Res. Paediatr."},{"key":"1303_CR124","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1210\/jc.2003-030512","volume":"88","author":"V Boonstra","year":"2003","unstructured":"Boonstra, V., van Pareren, Y., Mulder, P. & Hokken-Koelega, A. Puberty in growth hormone-treated children born small for gestational age (SGA). J. Clin. Endocrinol. Metab. 88, 5753\u20135758 https:\/\/doi.org\/10.1210\/jc.2003-030512 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR125","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1210\/jc.2016-1317","volume":"101","author":"M van der Steen","year":"2016","unstructured":"van der Steen, M., Lem, A. J., van der Kaay, D. C. & Hokken-Koeelega, A. C. Puberty and pubertal growth in GH-treated SGA children: effects of 2 years of GnRHa versus no GnRHa. J. Clin. Endocrinol. Metab. 101, 2005\u20132012 https:\/\/doi.org\/10.1210\/jc.2016-1317 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR126","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2213-8587(16)30422-3","volume":"5","author":"M van der Steen","year":"2017","unstructured":"van der Steen, M., Smeets, C. C., Kerkhof, G. F. & Hokken-Koelega, A. C. Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study. Lancet Diabetes Endocrinol. 5, 106\u2013116 https:\/\/doi.org\/10.1016\/S2213-8587(16)30422-3 (2017).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1303_CR127","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1210\/jc.2012-1987","volume":"97","author":"AJ Lem","year":"2012","unstructured":"Lem, A. J. et al. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J. Clin. Endocrinol. Metab. 97, 4096\u20134105 https:\/\/doi.org\/10.1210\/jc.2012-1987 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR128","doi-asserted-by":"publisher","DOI":"10.1159\/000550979","author":"A Perriere","year":"2026","unstructured":"Perriere, A. et al. Assessment of combined growth hormone and gonadotropin-releasing hormone analogue treatment in children with Silver\u2013Russell syndrome. Horm. Res. Paediatr. https:\/\/doi.org\/10.1159\/000550979 (2026).","journal-title":"Horm. Res. Paediatr."},{"key":"1303_CR129","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","volume":"2","author":"DJ Barker","year":"1989","unstructured":"Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight in infancy and death from ischaemic heart disease. Lancet 2, 577\u2013580 (1989).","journal-title":"Lancet"},{"key":"1303_CR130","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/s0140-6736(96)04257-2","volume":"348","author":"CN Martyn","year":"1996","unstructured":"Martyn, C. N., Barker, D. J. & Osmond, C. Mothers\u2019 pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 348, 1264\u20131268 https:\/\/doi.org\/10.1016\/s0140-6736(96)04257-2 (1996).","journal-title":"Lancet"},{"key":"1303_CR131","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/bmj.315.7105.396","volume":"315","author":"JW Rich-Edwards","year":"1997","unstructured":"Rich-Edwards, J. W. et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 315, 396\u2013400 https:\/\/doi.org\/10.1136\/bmj.315.7105.396 (1997).","journal-title":"BMJ"},{"key":"1303_CR132","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1001\/jama.292.22.2755","volume":"292","author":"R Huxley","year":"2004","unstructured":"Huxley, R. et al. Birth weight and subsequent cholesterol levels: exploration of the \u201cfetal origins\u201d hypothesis. JAMA 292, 2755\u20132764 https:\/\/doi.org\/10.1001\/jama.292.22.2755 (2004).","journal-title":"JAMA"},{"key":"1303_CR133","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ije\/dyg201","volume":"32","author":"L Lauren","year":"2003","unstructured":"Lauren, L. et al. Relationship between birthweight and blood lipid concentrations in later life: evidence from the existing literature. Int. J. Epidemiol. 32, 862\u2013876 https:\/\/doi.org\/10.1093\/ije\/dyg201 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"1303_CR134","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1464-5491.2003.00871.x","volume":"20","author":"CA Newsome","year":"2003","unstructured":"Newsome, C. A. et al. Is birth weight related to later glucose and insulin metabolism? \u2014 a systematic review. Diabet. Med. 20, 339\u2013348 https:\/\/doi.org\/10.1046\/j.1464-5491.2003.00871.x (2003).","journal-title":"Diabet. Med."},{"key":"1303_CR135","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/08035250600719754","volume":"95","author":"KK Ong","year":"2006","unstructured":"Ong, K. K. & Loos, R. J. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr. 95, 904\u2013908 https:\/\/doi.org\/10.1080\/08035250600719754 (2006).","journal-title":"Acta Paediatr."},{"key":"1303_CR136","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1210\/jc.2017-02589","volume":"103","author":"G Patti","year":"2018","unstructured":"Patti, G. et al. Clinical manifestations and metabolic outcomes of seven adults with Silver\u2013Russell syndrome. J. Clin. Endocrinol. Metab. 103, 2225\u20132233 https:\/\/doi.org\/10.1210\/jc.2017-02589 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR137","doi-asserted-by":"publisher","first-page":"e2001","DOI":"10.1210\/clinem\/dgae074","volume":"109","author":"O Lokulo-Sodipe","year":"2024","unstructured":"Lokulo-Sodipe, O. et al. Body composition and metabolism in adults with molecularly confirmed Silver\u2013Russell syndrome. J. Clin. Endocrinol. Metab. 109, e2001\u2013e2008 https:\/\/doi.org\/10.1210\/clinem\/dgae074 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR138","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1210\/jc.2016-3388","volume":"102","author":"CC Smeets","year":"2017","unstructured":"Smeets, C. C., Renes, J. S., van der Steen, M. & Hokken-Koelega, A. C. Metabolic health and long-term safety of growth hormone treatment in Silver\u2013Russell syndrome. J. Clin. Endocrinol. Metab. 102, 983\u2013991 https:\/\/doi.org\/10.1210\/jc.2016-3388 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR139","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1086\/508902","volume":"79","author":"L Feuk","year":"2006","unstructured":"Feuk, L. et al. Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am. J. Hum. Genet. 79, 965\u2013972 https:\/\/doi.org\/10.1086\/508902 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"1303_CR140","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/adc.71.6.490","volume":"71","author":"KY Lai","year":"1994","unstructured":"Lai, K. Y., Skuse, D., Stanhope, R. & Hindmarsh, P. Cognitive abilities associated with the Silver\u2013Russell syndrome. Arch. Dis. Child. 71, 490\u2013496 (1994).","journal-title":"Arch. Dis. Child."},{"key":"1303_CR141","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/mds.25483","volume":"28","author":"EF Augustine","year":"2013","unstructured":"Augustine, E. F., Blackburn, J., Pellegrino, J. E., Miller, R. & Mink, J. W. Myoclonus-dystonia syndrome associated with Russell Silver syndrome. Mov. Disord. 28, 841\u2013842 https:\/\/doi.org\/10.1002\/mds.25483 (2013).","journal-title":"Mov. Disord."},{"key":"1303_CR142","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000048102","volume":"56","author":"V Rizzo","year":"2001","unstructured":"Rizzo, V., Traggiai, C. & Stanhope, R. Growth hormone treatment does not alter lower limb asymmetry in children with Russell\u2013Silver syndrome. Horm. Res. 56, 114\u2013116 https:\/\/doi.org\/10.1159\/000048102 (2001).","journal-title":"Horm. Res."},{"key":"1303_CR143","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/01241398-200409000-00017","volume":"24","author":"E Abraham","year":"2004","unstructured":"Abraham, E., Altiok, H. & Lubicky, J. P. Musculoskeletal manifestations of Russell\u2013Silver syndrome. J. Pediatr. Orthop. 24, 552\u2013564 (2004).","journal-title":"J. Pediatr. Orthop."},{"key":"1303_CR144","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jspd.2014.06.003","volume":"3","author":"KT Yamaguchi Jr.","year":"2015","unstructured":"Yamaguchi, K. T. Jr., Salem, J. B., Myung, K. S., Romero, A. N. Jr. & Skaggs, D. L. Spinal deformity in Russell\u2013Silver syndrome. Spine Deform. 3, 95\u201397 https:\/\/doi.org\/10.1016\/j.jspd.2014.06.003 (2015).","journal-title":"Spine Deform."},{"key":"1303_CR145","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1210\/jc.2008-1844","volume":"94","author":"RF de Lind van Wijngaarden","year":"2009","unstructured":"de Lind van Wijngaarden, R. F. et al. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader\u2013Willi syndrome. J. Clin. Endocrinol. Metab. 94, 1274\u20131280 https:\/\/doi.org\/10.1210\/jc.2008-1844 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1303_CR146","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.21037\/tp-24-180","volume":"13","author":"C Luo","year":"2024","unstructured":"Luo, C. et al. Effect of growth hormone to spinal growth and recombinant human growth hormone to scoliosis. Transl. Pediatr. 13, 1849\u20131857 https:\/\/doi.org\/10.21037\/tp-24-180 (2024).","journal-title":"Transl. Pediatr."},{"key":"1303_CR147","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1439-0280.2003.2c209.x","volume":"6","author":"A Bergman","year":"2003","unstructured":"Bergman, A., Kjellberg, H. & Dahlgren, J. Craniofacial morphology and dental age in children with Silver\u2013Russell syndrome. Orthod. Craniofac Res. 6, 54\u201362 (2003).","journal-title":"Orthod. Craniofac Res."},{"key":"1303_CR148","first-page":"135","volume":"82","author":"N Hodge","year":"2015","unstructured":"Hodge, N., Evans, C. A., Simmons, K. E., Fadavi, S. & Viana, G. Occlusal characteristics of individuals with growth hormone deficiency, idiopathic short stature, and Russell\u2013Silver syndrome. J. Dent. Child. 82, 135\u2013140 (2015).","journal-title":"J. Dent. Child."},{"key":"1303_CR149","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jormas.2018.10.011","volume":"120","author":"S Vo Quang","year":"2018","unstructured":"Vo Quang, S. et al. Contribution of a better maxillofacial phenotype in Silver\u2013Russell syndrome to define a better orthodontics and surgical management. J. Stomatol. Oral. Maxillofac. Surg. 120, 110\u2013115 https:\/\/doi.org\/10.1016\/j.jormas.2018.10.011 (2018).","journal-title":"J. Stomatol. Oral. Maxillofac. Surg."},{"key":"1303_CR150","doi-asserted-by":"publisher","first-page":"392","DOI":"10.17796\/1053-4628-41.5.392","volume":"41","author":"SJ Ko","year":"2017","unstructured":"Ko, S. J., Seo, J. Y., Kwon, Y. D., Cheon, K. & Park, J. H. Orthodontic treatment in conjunction with twin-bock treatment and growth hormone therapy in Silver Russell syndrome. J. Clin. Pediatr. Dent. 41, 392\u2013397 https:\/\/doi.org\/10.17796\/1053-4628-41.5.392 (2017).","journal-title":"J. Clin. Pediatr. Dent."},{"key":"1303_CR151","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0889-5406(99)70299-4","volume":"116","author":"RS Kisnisci","year":"1999","unstructured":"Kisnisci, R. S., Fowel, S. D. & Epker, B. N. Distraction osteogenesis in Silver Russell syndrome to expand the mandible. Am. J. Orthod. Dentofac. Orthop. 116, 25\u201330 (1999).","journal-title":"Am. J. Orthod. Dentofac. Orthop."},{"key":"1303_CR152","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.sleep.2019.05.020","volume":"64","author":"E Giabicani","year":"2019","unstructured":"Giabicani, E. et al. Sleep disordered breathing in Silver\u2013Russell syndrome patients: a new outcome. Sleep. Med. 64, 23\u201329 https:\/\/doi.org\/10.1016\/j.sleep.2019.05.020 (2019).","journal-title":"Sleep. Med."},{"key":"1303_CR153","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ajmg.a.35691","volume":"161A","author":"M Ghanim","year":"2013","unstructured":"Ghanim, M. et al. Possible association between complex congenital heart defects and 11p15 hypomethylation in three patients with severe Silver\u2013Russell syndrome. Am. J. Med. Genet. A 161A, 572\u2013577 https:\/\/doi.org\/10.1002\/ajmg.a.35691 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"1303_CR154","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/jpc.12778","volume":"51","author":"MB Abraham","year":"2015","unstructured":"Abraham, M. B. et al. Report and review of described associations of Mayer\u2013Rokitansky\u2013Kuster\u2013Hauser syndrome and Silver\u2013Russell syndrome. J. Paediatr. Child. Health 51, 555\u2013560 https:\/\/doi.org\/10.1111\/jpc.12778 (2015).","journal-title":"J. Paediatr. Child. Health"},{"key":"1303_CR155","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/archdischild-2018-314952","volume":"104","author":"LM Ballard","year":"2019","unstructured":"Ballard, L. M. et al. Lived experience of Silver\u2013Russell syndrome: implications for management during childhood and into adulthood. Arch. Dis. Child. 104, 76\u201382 https:\/\/doi.org\/10.1136\/archdischild-2018-314952 (2019).","journal-title":"Arch. Dis. Child."},{"key":"1303_CR156","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/archdischild-2020-321376","volume":"106","author":"LM Ballard","year":"2021","unstructured":"Ballard, L. M. et al. Experiences of adolescents living with Silver\u2013Russell syndrome. Arch. Dis. Child. 106, 1195\u20131201 https:\/\/doi.org\/10.1136\/archdischild-2020-321376 (2021).","journal-title":"Arch. Dis. Child."},{"key":"1303_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104482","volume":"65","author":"M Burgevin","year":"2022","unstructured":"Burgevin, M. et al. Quality of life and mental health of adolescents and adults with Silver\u2013Russell syndrome. Eur. J. Med. Genet. 65, 104482 https:\/\/doi.org\/10.1016\/j.ejmg.2022.104482 (2022).","journal-title":"Eur. J. Med. Genet."},{"key":"1303_CR158","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.beem.2010.09.004","volume":"25","author":"K Hoffmann","year":"2011","unstructured":"Hoffmann, K. & Heller, R. Uniparental disomies 7 and 14. Best. Pract. Res. Clin. Endocrinol. Metab. 25, 77\u2013100 https:\/\/doi.org\/10.1016\/j.beem.2010.09.004 (2011).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1303_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01259-x","volume":"14","author":"T Eggermann","year":"2022","unstructured":"Eggermann, T. et al. Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences. Clin. Epigenetics 14, 41 https:\/\/doi.org\/10.1186\/s13148-022-01259-x (2022).","journal-title":"Clin. Epigenetics"},{"key":"1303_CR160","doi-asserted-by":"publisher","DOI":"10.1530\/EC-24-0091","volume":"13","author":"MG Shaikh","year":"2024","unstructured":"Shaikh, M. G. et al. Prader\u2013Willi syndrome: guidance for children and transition into adulthood. Endocr. Connect. 13, e240091 https:\/\/doi.org\/10.1530\/EC-24-0091 (2024).","journal-title":"Endocr. Connect."},{"key":"1303_CR161","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jmedgenet-2014-102396","volume":"51","author":"Y Ioannides","year":"2014","unstructured":"Ioannides, Y., Lokulo-Sodipe, K., Mackay, D. J., Davies, J. H. & Temple, I. K. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J. Med. Genet. 51, 495\u2013501 https:\/\/doi.org\/10.1136\/jmedgenet-2014-102396 (2014).","journal-title":"J. Med. Genet."},{"key":"1303_CR162","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000530420","volume":"96","author":"AF Juriaans","year":"2023","unstructured":"Juriaans, A. F. et al. The effects of 5 years of growth hormone treatment on growth and body composition in patients with Temple syndrome. Horm. Res. Paediatr. 96, 483\u2013494 https:\/\/doi.org\/10.1159\/000530420 (2023).","journal-title":"Horm. Res. Paediatr."},{"key":"1303_CR163","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ajmg.a.37346","volume":"170A","author":"G Severi","year":"2016","unstructured":"Severi, G. et al. New patients with Temple syndrome caused by 14q32 deletion: genotype\u2013phenotype correlations and risk of thyroid cancer. Am. J. Med. Genet. A 170A, 162\u2013169 https:\/\/doi.org\/10.1002\/ajmg.a.37346 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"1303_CR164","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ajmg.a.32612","volume":"149A","author":"JE Allanson","year":"2009","unstructured":"Allanson, J. E. et al. Elements of morphology: standard terminology for the head and face. Am. J. Med. Genet. A 149A, 6\u201328 https:\/\/doi.org\/10.1002\/ajmg.a.32612 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"1303_CR165","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/35013100","volume":"405","author":"AC Bell","year":"2000","unstructured":"Bell, A. C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482\u2013485 https:\/\/doi.org\/10.1038\/35013100 (2000).","journal-title":"Nature"},{"key":"1303_CR166","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/35013106","volume":"405","author":"AT Hark","year":"2000","unstructured":"Hark, A. T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19\/Igf2 locus. Nature 405, 486\u2013489 https:\/\/doi.org\/10.1038\/35013106 (2000).","journal-title":"Nature"},{"key":"1303_CR167","first-page":"717","volume":"34","author":"C Sheridan","year":"2005","unstructured":"Sheridan, C. Intrauterine growth restriction \u2014 diagnosis and management. Aust. Fam. Physician 34, 717\u2013723 (2005).","journal-title":"Aust. Fam. Physician"},{"key":"1303_CR168","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3126\/nmj.v7il.80076","volume":"7","author":"GR Raj Arun","year":"2025","unstructured":"Raj Arun, G. R., Mokindan, R., Chavan, R., Patel, M. & Shirole, S. Clinical diagnosis of Silver\u2013Russel syndrome using Netchine\u2013Harbison criteria in a resource-limited setting. Nepal. Med. J. 7, 715\u2013717 https:\/\/doi.org\/10.3126\/nmj.v7il.80076 (2025).","journal-title":"Nepal. Med. J."},{"key":"1303_CR169","unstructured":"World Health Organization. WHO recommendations for care of the preterm or low-birth-weight infant. WHO https:\/\/www.who.int\/publications\/i\/item\/9789240058262 (2022)."},{"key":"1303_CR170","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/apa.13133","volume":"104","author":"BL Horta","year":"2015","unstructured":"Horta, B. L., Loret de Mola, C. & Victora, C. G. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 104, 30\u201337 https:\/\/doi.org\/10.1111\/apa.13133 (2015).","journal-title":"Acta Paediatr."}],"updated-by":[{"DOI":"10.1038\/s41574-026-01313-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000}}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01303-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:06:23Z","timestamp":1790780783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01303-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":170,"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1038\/s41574-026-01303-3","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"27 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41574-026-01313-1","URL":"https:\/\/doi.org\/10.1038\/s41574-026-01313-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.B. has received consultancy honoraria from Pfizer. G.B. has received lecture fees and consultancy honoraria from pharmaceutical companies involved in the production of recombinant growth hormone. M.M. has received research support, consultancy honoraria and lecture fees from BioMarin, Pfizer, Novo Nordisk, Merck and Sandoz. I.N. has received research support and lecture fees from Pfizer, Novo Nordisk, Merck and Sandoz. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}